CIK: 0001542339
Total reported value
$250.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABMDEUR | Abiomed INC | Stock-Other | 41.42% | — | — | |
| 2 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 21.79% | — | — | |
| 3 | AXGN | Axogen INC | Stock-Other | 11.59% | — | — | |
| 4 | ✓ | Entellus Medical INC | Stock-Other | 10.18% | — | -15.25% | |
| 5 | ✓ | Corium Intl INC | Stock-Other | 8.92% | — | — | |
| 6 | ✓ | Endologix INC | Stock-Other | 3.30% | — | — | |
| 7 | MNOV | Medicinova INC | Stock-Other | 1.60% | +0.14% | — | |
| 8 | LGND | Ligand Pharmaceuticals | Stock-Healthcare | 0.75% | — | -5.77% | |
| 9 | ACUR | Acura Pharmaceuticals INC | Stock-Other | 0.27% | — | — | |
| 10 | ✓ | Catalyst Biosciences INC | Stock-Other | 0.17% | — | -93.33% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ABMDEUR | Abiomed INC | +4.2% | — | Unchanged |
| 2 | AXGN | Axogen INC | +1.6% | — | Unchanged |
| 3 | ✓ | Corium Intl INC | +0.3% | — | Unchanged |
| 4 | LGND | Ligand Pharmaceuticals | +0.2% | -5.77% | Trim |
| 5 | RVNCEUR | Revance Therapeutics INC | +0.1% | — | Unchanged |
| 6 | ✓ | Endologix INC | +0.1% | — | Unchanged |
| 7 | MNOV | Medicinova INC | 0% | — | Unchanged |
| 8 | ✓ | Catalyst Biosciences INC | 0% | -93.33% | Trim |
| 9 | ACUR | Acura Pharmaceuticals INC | -0.1% | — | Unchanged |
| 10 | ✓ | Entellus Medical INC | -6.3% | -15.25% | Trim |